We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Cadila Healthcare

News List

Cadila Healthcare’s net profit rises 29 per cent in Q1 expresspharma
August 13, 2021
Cadila Healthcare 10th reported a 29.33 per cent rise in its consolidated net profit to Rs 587.2 crores for the quarter ended on 30th June, 2021, mainly on account of robust sales in the Indian market.
India gives restricted emergency use approval for two Covid-19 vaccines pharmaceutical-business-review
January 06, 2021
India's Central Drugs Standard Control Organisation (CDSCO) has given the restricted emergency use approval for Covid-19 vaccines of Serum Institute of India and Bharat Biotech.
US FDA for voluntary action by Cadila Healthcare on Ahmedabad SEZ facility expresspharma
June 21, 2019
Drug firm Cadila Healthcare announced that it has received establishment inspection report from the US health regulator with voluntary action indicated (VAI) classification for its Ahmedabad SEZ facility.
Cadila Healthcare posts Q4 net profit of Rs 460 cr expressbpd
May 30, 2019
The company said its board has recommended a dividend of Rs 3.50 per equity share on 1,02,37,42,600 equity shares of Re 1 each for the financial year ended on March 31, 2019
Cadila Healthcare arm gets USFDA nod for ulcer treatment injection expressbpd
December 12, 2018
Cadila Healthcare said the product will be manufactured at Liva Pharma’s manufacturing facility at Vadodara